Summary
Sequential paraffin sections of 222 epithelial lung tumors comprising all common histologic types, and 31 pleural mesotheliomas of all variants were immunostained with monoclonal antibodies (Mabs) B72.3 and CSLEX-1. Reactivity with Mabs B72.3 and CSLEX-1 respectively was noted in 7/57 and 4/57 squamous carcinomas, in 44/70 and 60/70 adenocarcinomas, 9/16 and 11/16 bronchioloalveolar carcinomas, 8/25 and 14/25 large cell undifferentiated carcinomas, 3/3 and 3/3 adenosquamous carcinomas, 0/11 and 0/11 carcinoids, 0/10 and 2/10 well differentiated neuroendocrine (NE) carcinomas, 4/13 and 5/13 intermediate cell NE carcinomas, 0/17 and 0/17 small cell NE carcinomas, and 0/31 and 1/31 mesotheliomas. In most instances, both Mabs stained the same tumors; however, reactivity with CSLEX-1 was more intense and extensive, and involved more cases. Therefore, regardless of conventional histologic type, staining with Mabs B72.3 and CSLEX-1 defines 4 subsets of lung tumors: one expressing both antigens, two expressing one but not the other, and one expressing neither. The possible biological and/or clinical significance of these subsets remains undetermined. When correlated with conventional histologie tumor types, our findings indicate: 1). both of these Mabs recognize most but not all adenocarcinomas and bronchioloalveolar carcinomas, and since CSLEX-1 stained more cases than B72.3, it may be argued that the former is a broader exocrine phenotype marker than the latter; 2). both of these Mabs select exocrine subsets of large cell undifferentiated carcinomas; 3). both of these Mabs stain exocrine cell subpopulations in well differentiated and intermediate cell NE carcinomas but not in carcinoids or small cell NE carcinomas, and 4). except for rare cases, neither B72.3 nor CSLEX-1 reacts with mesotheliomas regardless of variant. These immunoreactivity patterns are comparable but not identical with those previously reported for Mabs 44–3A6, 624A12 and A-80. Given that the antigen recognized by Mab CSLEX-1 is detectable in serum, it may be possible to combine histologie and clinical CSLEX-1 immunolabelling for diagnosing and monitoring certain lung carcinomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aminoff D, Fulton I, Ingelbrigtsen N (1976) Effect of sialidase on the viability of erythrocytes. Am J Hematol 1: 419–432
Blobel GA, Gould VE, Moll R, Lee I, Huszar M, Geiger B, Franke WW (1985a) Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Lab Invest 52:39–51
Blobel GA, Kayser K, Franke WW, Gould VE (1985b) The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 121:235–247
Carter D, Eggleston JC (1979) Tumors of the lower respiratory tract. Atlas of tumor pathology, Second series, Fascicle 17. Armed Forces Institute of Pathology, Washington DC
Coon JS, Weinstein RS (1986) Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas. Hum Pathol 17:1089–1106
Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD (1985) Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature 316:823–824
Decenzo JM, Howard P, Irish CE (1975) Antigenic deletion and prognosis of patients with stage A transitional cell carcinoma. J Urol 114:874–878
Dennis JW, Laferte S (1985) Recognition of asparagine-linked oligosaccharides on murine tumor cells by natural killer cells. Cancer Res 45:6034–6040
Fukushima K, Hirota M, Terasaki P, Wakisaka A, Togashi H, Chia D, Naofumi S, Fukushi Y, Nudelman E, Hakomori SI (1984) Characterization of sialosylated Lewis X as a new tumor antigen. Cancer Res 44:5279–5285
Gould VE, Lee 1, Warren WH (1988) Immunohistochemical evaluation of neuroendocrine cells and neoplasms of the lung. Pathol Res Pract 183:200–213
Gould VE, Linnoila RI, Memoli VA, Warren WH (1983a) Neuroendocrine components of the bronchopulmonary tract ; hyperplasias, dysplasias and neoplasms. Lab Invest 49:519–537
Gould VE, Linnoila RI, Memoli VA, Warren WH (1983b) Neuroendocrine cells and neuroendocrine neoplasms of lung. Pathol Annu 18:287–330
Gould VE, Memoli VA, Dardi LE (1981) Multidirectional differentiation in human epithelial concers. J Submicrosc Cytol 13:97–115
Gould VE, Moll R, Chejfec G, Franke WW (1988) Cytoskeletal characteristics of epithelial neoplasms of the lung. In: Rosen ST, Mulshine JL, Cuttitta F, Abrams PG (eds) Biology of lung cancer: diagnosis and treatment. Marcel Dekker, New York, pp 121–154
Gould VE, Shin SS, Manderino GL, Rittenhouse HG, Tomita JT, Gooch TG (1988) Selective expression of a novel mucin-type glycoprotein in human tumors. Hum Pathol 19:623–627
Gould VE, Warren WH (1989) Epithelial neoplasms of the lung. In: Roth JA, Ruckdeschel JC, Weisenburger TH (eds) Thoracic oncology. WB Saunders, Philadelphia, pp 77–93
Hakomori S (1985) Aberrant glycosylation in cancer cell membranes as focused on glycolipids; overview and perspectives. Cancer Res 45:2405–2414
Hsu SM, Raine L, Fanger H (1982) The use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody PAP procedure. J Histochem Cytochem 29:577–581
Jansson D, Gould VE, Gooch GT, Rittenhouse HG, Shin SS, Manderino GL, Tomita JT, Staren ED (1988) Immunohistochemical analysis of colon carcinomas applying exocrine and neuroendocrine markers. APMIS 96:1129–1139
Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D (1986) Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 46:850–857
Johnston WW, Szpak CA, Thor A, Schlom J (1986) Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3. Cancer Res 46:6462–6470
Kasai K, Kameya T, Okuda T, Terasaki PI, Iwaki Y (1986) Immunohistochemical examination of lung cancers using monoclonal antibodies reacting with sialosylated Lewisx and sialosylated Lewisa. Virchows Arch [A] 410:253–261
Kerr MA, McCarthy NC (1985) A carbohydrate differentiation antigen of granulocytes, brain, and many tumours. Biochem Soc Trans 13:424–426
Kreyberg L (1984) Cancer epidemiology. Some methodological reflections. Acta Pathol Microbiol Immunol Scand (A) [Suppl 92] 285:1–16
Lange PH, Limas C (1984) Molecular markers in the diagnosis and prognosis of bladder cancer. Urology [Suppl] 23:46–54
Lee I, Gould VE, Moll R, Wiedenmann B, Franke WW (1987a) Synaptophysin expressed in the bronchopulmonary tract: neuroendocrine cells, neuroepithelial bodies and neuroendocrine neoplasms. Differentiation 34:115–125
Lee I, Gould VE, Radosevich JA, Thor A, Ma Y, Schlom J, Rosen ST (1987 b) Immunohistochemical evaluation of ras oncogene expression in pulmonary and pleural neoplasms. Virchows Arch [B] 53:146–152
Lee I, Radosevich JH, Chejfec G, Ma Y, Warren W, Rosen ST, Gould VE (1986) Malignant mesotheliomas; improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44–3A6 and 624A12. Am J Pathol 123:497–507
Lee I, Radosevich JA, Ma Y, Combs SG, Rosen ST, Gould VE (1985) Immunohistochemical analysis of pulmonary carcinomas using monoclonal antibody 44–3A6. Cancer Res 45:5813–5817
Moll R, Lee I, Gould VE, Berndt R, Roessner A, Franke WW (1987) Immunocytochemical analysis of Ewing’s tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation. Am J Pathol 127:288–304
Piehl MR, Gould VE, Warren WH, Lee I, Radosevich JA, Ma Y, Rosen ST (1988) Immunohistochemical identification of exocrine and neuroendocrine subsets of large cell lung carcinomas. Pathol Res Pract 183:675–682
Race R, Sanger R (1975) Blood groups in man. Blackwell, Oxford, UK, chapter 2
Radosevich JA, Gould VE, Ma Y, Lee I, Thor A, Carney WP, Warren WH, Schlom J, Rosen ST (1989) Immunohistochemical analysis of normal and mutated ras oncogene p 21 expression in human pulmonary and pleural neoplasms. Virchows Arch [B] 56:377–383
Radosevich JA, Ma Y, Lee I, Salwen HR, Gould VE, Rosen ST (1985) Monoclonal antibody 44–3A6 as a probe for a novel antigen present in lung carcinomas with glandular differentiation. Cancer Res 45:5808–5812
Rauvala H (1976) Gangliosides of human kidney. J Biol Chem 251:7517–7520
Rittenhouse HG, Manderino GL, Hass GM (1985): Mucin-type glycoproteins as tumor markers. Lab Med 16:556–560
Said JW, Nash G, Tepper G, Banks-Schlegel S (1983) Keratin proteins and carcinoembryonic antigen in lung carcinoma. Hum Pathol 14:70–76
Shin SS, Gould VE, Gould JE, Warren WH, Gould KA, Yaremko ML, Manderino GL, Rittenhouse HG, Tomita JT, Jansson DS, Staren ED, Chejfec G, Gooch GT (1990) Expression of a new mucin-type glycoprotein in select epithelial dysplasia and neoplasms detected immunocytochemically with mab A-80. SP MIS (in press)
Staren Ed, Gould VE, Jansson DS, Hayser M, Gooch GT, Economou SG (1990) Neuroendocrine differentiation in “poorly differentiated” colon carcinomas. Am Surg (in press)
Thor A, Ohushi N, Szpak CA, Johnston WW, Schlon J (1986) Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 46:3118–3124
Weinstein RS, Schwartz D, Coon JS (1986) Blood group antigens and ploidy as prognostic factors in urinary bladder carcinoma. In: Fenoglio-Preiser CM, Weinstein RS, Kaufman N (eds) New concepts in neoplasia as applied to diagnostic pathology. Williams & Wilkins, Baltimore, pp 225–241
Werkmeister JA, Pross HF, Ruder JC (1983) Modulation of K562 cells with sodium butyrate. Association of impaired NK susceptibility with sialic acid and analysis of other parameters. Int J Cancer 32:81–78
Willey JC, Lechner JF, Harris CC (1984) Bombesin and the Cterminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. Exp Cell Res 153:245–248
World Health Organization: Histological typing of lung tumors. Geneva (1967) World Health organization (1982) Histological typing of lung tumors. Second Ed. Am J Clin Pathol 77:123–136
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koukoulis, G.K., Radosevich, J.A., Warren, W.H. et al. Immunohistochemical, analysis of pulmonary and pleural neoplasms with monoclonal antibodies B72.3 and CSLEX-1. Virchows Archiv B Cell Pathol 58, 427–433 (1989). https://doi.org/10.1007/BF02890102
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02890102